This inventor holds 4 USPTO granted patents. Top assignees: Budesrepublik Deutschland Vertreten Durch Den Bundesminister, Budresrepublik Deutschland Vertreten Durch Den Bundesminister Fur, Other. Active years: 1999-2002.
Company Filing History:
1 out of 1 
1 out of 1 
2 out of 834,350 Years Active: 1999-2002
Title: The Innovative Contributions of Karin Metzner
Introduction
Karin Metzner is a prominent inventor based in Frankfurt-am-Main, Germany. She has made significant contributions to the field of immunology, particularly in the development of methods for treating viral infections. With a total of 4 patents to her name, her work has the potential to impact the treatment of various viral diseases.
Latest Patents
One of her latest patents is focused on a method of identifying compounds capable of activating Immunodeficiency-virus Suppressing Lymphokine (ISL) production. This invention is directed towards the cloning and isolation of nucleic acid molecules for eukaryotic ISL. The ISL produced by stimulated CD8+ PBMC is capable of suppressing the replication of viruses, especially retroviruses, both in vitro and in vivo. The patent describes a method for detecting compounds that induce the expression of ISL by measuring its presence and its ability to inhibit HIV transcription. Another significant patent involves genomic nucleic acids, cDNA, and mRNA that code for polypeptides with interleukin-16 activity. This invention outlines processes for producing IL-16 in eukaryotic host cells and pharmaceutical compositions containing the same.
Career Highlights
Throughout her career, Karin Metzner has worked with various organizations, including the Federal Republic of Germany, represented by the Federal Minister. Her innovative work has positioned her as a key figure in the field of immunology.
Collaborations
Karin has collaborated with notable individuals such as Reinhard Kurth and Michael Baier. These collaborations have further enhanced her research and contributions to the scientific community.
Conclusion
Karin Metzner's innovative work in the field of immunology, particularly her patents related to ISL and interleukin-16, showcases her dedication to advancing medical science. Her contributions have the potential to lead to significant advancements in the treatment of viral infections.